A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The study will look at the safety profile (unwanted effects) of the long-lasting
anticoagulant PEG-hirudin (SPP200) and compare these unwanted effects to those of
unfractionated heparin, commonly used in haemodialysis to avoid clotting of the graft and of
the haemodialysis machine.